Raynaud phenomenon

Raynaud phenomenon is a condition in which blood vessels narrow and blood flow drops. MedlinePlus says the attacks usually affect the fingers and toes, which become cold and numb and may turn white or blue, in response to cold temperatures or stress. An attack may last a few minutes or a few hours. MedlinePlus describes two types: primary Raynaud phenomenon, the more common type, whose cause is unknown, and secondary Raynaud phenomenon, which is usually caused by another disease or problem such as lupus or scleroderma and can be more serious than the primary type. MeSH describes the idiopathic form as a vascular disorder with a sudden onset of digital paleness or cyanosis in response to cold or stress.

Also called Raynaud disease · Raynaud's disease · Raynaud syndrome

  • Condition
  • In this atlas

Overview

Technical summary

MeSH Raynaud Disease (D011928, recorded as a broad match, not exact). The descriptor's preferred concept is the idiopathic form, and its scope note describes only that form; Raynaud Phenomenon is a narrower concept inside the same descriptor (M0449202, which has no scope note of its own). This page covers both the primary and the secondary type, as MedlinePlus does under the name Raynaud phenomenon, so the descriptor's scope note does not match the whole page. The record gives no cause list beyond the two examples MedlinePlus names, no medicine, and no self-care advice; the page's own lists of risk factors, medicines that can make symptoms worse and self-care steps are not used. The evidence recorded is descriptive and comes from a vocabulary entry and a patient information page, with no study data.

Recognition

MedlinePlus says an attack makes the skin cold and numb, may turn it white or blue, and can bring tingling, throbbing or redness as blood flow returns.

Classification codes

  • MeSH MeSH linked-data descriptor record fetched on 2026-11-18, lastUpdated 2021-10-18; the record states no yearly MeSH release D011928

Burden

No burden claims are published.

Claims and evidence

Context People with Raynaud phenomenon (MeSH scope note and MedlinePlus health topic)

Recipient
Recipient not specified
Population
People with primary or secondary Raynaud phenomenon, as the MedlinePlus page describes it; the MeSH scope note describes the idiopathic form.
Care setting
Not stated for the description. The page also describes self-care and treatment; none is used here.
Geography
Not stated. The sources do not name a country.
Life stage
Not restricted by the sources. The page says primary Raynaud phenomenon often starts in the teenage years; this record makes no statement about pregnancy, newborns or children.
Gestational age
Not reported
Postnatal age
Not reported
Follow-up
Not applicable (a description of a condition).
Eligibility: 1 inclusion criterion; exclusion criteria not stated
Included
  • Raynaud phenomenon, primary or secondary
Excluded
None stated
  • Description Evidence stage unknown Certainty not assessed

    MedlinePlus says Raynaud phenomenon acts on the blood vessels, making them narrow so that less blood flows, and that the attacks usually affect the fingers and toes, making them cold and numb and sometimes white or blue, in response to cold temperatures or stress. It says an attack may last a few minutes or a few hours, that the condition may also be called Raynaud disease or Raynaud syndrome, and that there are two types: primary, the more common, whose cause is unknown, and secondary, which is usually caused by another disease or problem such as lupus or scleroderma and can be more serious than the primary type. MeSH describes Raynaud disease as an idiopathic vascular disorder with bilateral Raynaud phenomenon, the abrupt onset of digital paleness or cyanosis in response to cold exposure or stress.

    Applies to Recipient not specified People with Raynaud phenomenon (MeSH scope note and MedlinePlus health topic)

    Certainty method
    Not assessed
    Limitations
    General patient information and a vocabulary note, not a diagnostic or treatment rule. The sources give no figures or study data. The page's lists of risk factors, medicines that can make symptoms worse, self-care steps and treatments are not repeated, and the atlas gives no care instructions. MeSH's scope note is about the idiopathic form only.
    Last checked
    2026-11-18
    Next evidence check due
    Not scheduled
    Sources and citations (13)
    1. Background MeSH concept M0449202 (Raynaud Phenomenon) within descriptor D011928

      Dataset · U.S. National Library of Medicine · Edition MeSH linked-data record of the concept M0449202 (Raynaud Phenomenon), a narrower concept of descriptor D011928, fetched 2026-11-18. The record has a label and no scope note. · MeSH: M0449202

      Locator
      label.@value
      How it applies
      MeSH records Raynaud Phenomenon as a concept within the descriptor Raynaud Disease.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      db2348e8a09e1df59c233642cf920084ea882ced47589b058811be875ecb580c
      Reuse basis
      The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. The NLM MeSH terms and conditions page (sha256 f33b14141a5b6c8a2b1464c751dbdbb0a0d476c913851bf2a8c3d5c14b1afce7, hash only) asks redistributors to maintain current data or to make known that their copy may not reflect the most current data. This copy was fetched on 2026-11-18 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
    2. Supports MeSH scope note for descriptor D011928 (Raynaud Disease)

      Dataset · U.S. National Library of Medicine · Edition MeSH linked-data record of the preferred concept M0018534 of descriptor D011928, fetched 2026-11-18. The scope note is on this concept record, not on the descriptor record. · MeSH: M0018534

      Locator
      scopeNote.@value
      How it applies
      MeSH: an idiopathic vascular disorder with bilateral Raynaud phenomenon, the abrupt onset of digital paleness or cyanosis in response to cold or stress.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      5b9518f73eec53724961f035c7a1d88a87b9daa4d83339f5264ad8ea3a7fba5e
      Reuse basis
      The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. The NLM MeSH terms and conditions page (sha256 f33b14141a5b6c8a2b1464c751dbdbb0a0d476c913851bf2a8c3d5c14b1afce7, hash only) asks redistributors to maintain current data or to make known that their copy may not reflect the most current data. This copy was fetched on 2026-11-18 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
    3. Supports Raynaud Phenomenon (MedlinePlus health topic)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Health topic page fetched 2026-11-18. The page shows a last-updated or reviewed date; it is not used here.

      Locator
      What is Raynaud phenomenon?, paragraph 1, sentence 1
      How it applies
      It acts on the blood vessels.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      e289dc04cd9087c8072918e6d556369e72fbe0ea6a3ea05a2e27edb86836df80
      Reuse basis
      MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source. Terms checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, works produced by the federal government are not copyrighted, and users should acknowledge MedlinePlus, National Library of Medicine, as the source. It says A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted; this atlas cites none of them. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote. The raw page is committed in the atlas repository.
    4. Supports Raynaud Phenomenon (MedlinePlus health topic)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Health topic page fetched 2026-11-18. The page shows a last-updated or reviewed date; it is not used here.

      Locator
      What is Raynaud phenomenon?, paragraph 1, sentence 2
      How it applies
      It causes the blood vessels to narrow, which decreases blood flow.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      e289dc04cd9087c8072918e6d556369e72fbe0ea6a3ea05a2e27edb86836df80
      Reuse basis
      MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source. Terms checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, works produced by the federal government are not copyrighted, and users should acknowledge MedlinePlus, National Library of Medicine, as the source. It says A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted; this atlas cites none of them. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote. The raw page is committed in the atlas repository.
    5. Supports Raynaud Phenomenon (MedlinePlus health topic)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Health topic page fetched 2026-11-18. The page shows a last-updated or reviewed date; it is not used here.

      Locator
      What is Raynaud phenomenon?, paragraph 1, sentence 3 (part)
      How it applies
      The attacks usually affect the fingers and toes, which become cold and numb.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      e289dc04cd9087c8072918e6d556369e72fbe0ea6a3ea05a2e27edb86836df80
      Reuse basis
      MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source. Terms checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, works produced by the federal government are not copyrighted, and users should acknowledge MedlinePlus, National Library of Medicine, as the source. It says A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted; this atlas cites none of them. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote. The raw page is committed in the atlas repository.
    6. Supports Raynaud Phenomenon (MedlinePlus health topic)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Health topic page fetched 2026-11-18. The page shows a last-updated or reviewed date; it is not used here.

      Locator
      What is Raynaud phenomenon?, paragraph 1, sentence 4
      How it applies
      They may also change color, usually to white or blue.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      e289dc04cd9087c8072918e6d556369e72fbe0ea6a3ea05a2e27edb86836df80
      Reuse basis
      MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source. Terms checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, works produced by the federal government are not copyrighted, and users should acknowledge MedlinePlus, National Library of Medicine, as the source. It says A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted; this atlas cites none of them. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote. The raw page is committed in the atlas repository.
    7. Supports Raynaud Phenomenon (MedlinePlus health topic)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Health topic page fetched 2026-11-18. The page shows a last-updated or reviewed date; it is not used here.

      Locator
      What is Raynaud phenomenon?, paragraph 1, sentence 5
      How it applies
      Attacks happen in response to cold temperatures or stress.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      e289dc04cd9087c8072918e6d556369e72fbe0ea6a3ea05a2e27edb86836df80
      Reuse basis
      MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source. Terms checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, works produced by the federal government are not copyrighted, and users should acknowledge MedlinePlus, National Library of Medicine, as the source. It says A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted; this atlas cites none of them. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote. The raw page is committed in the atlas repository.
    8. Supports Raynaud Phenomenon (MedlinePlus health topic)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Health topic page fetched 2026-11-18. The page shows a last-updated or reviewed date; it is not used here.

      Locator
      What is Raynaud phenomenon?, paragraph 2, sentence 1
      How it applies
      It may also be called Raynaud disease or Raynaud syndrome.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      e289dc04cd9087c8072918e6d556369e72fbe0ea6a3ea05a2e27edb86836df80
      Reuse basis
      MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source. Terms checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, works produced by the federal government are not copyrighted, and users should acknowledge MedlinePlus, National Library of Medicine, as the source. It says A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted; this atlas cites none of them. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote. The raw page is committed in the atlas repository.
    9. Supports Raynaud Phenomenon (MedlinePlus health topic)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Health topic page fetched 2026-11-18. The page shows a last-updated or reviewed date; it is not used here.

      Locator
      What are the types of Raynaud phenomenon?, list item 1, sentence 1
      How it applies
      Primary Raynaud phenomenon is the more common type.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      e289dc04cd9087c8072918e6d556369e72fbe0ea6a3ea05a2e27edb86836df80
      Reuse basis
      MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source. Terms checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, works produced by the federal government are not copyrighted, and users should acknowledge MedlinePlus, National Library of Medicine, as the source. It says A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted; this atlas cites none of them. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote. The raw page is committed in the atlas repository.
    10. Supports Raynaud Phenomenon (MedlinePlus health topic)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Health topic page fetched 2026-11-18. The page shows a last-updated or reviewed date; it is not used here.

      Locator
      What are the types of Raynaud phenomenon?, list item 1, sentence 2
      How it applies
      Its cause is unknown.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      e289dc04cd9087c8072918e6d556369e72fbe0ea6a3ea05a2e27edb86836df80
      Reuse basis
      MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source. Terms checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, works produced by the federal government are not copyrighted, and users should acknowledge MedlinePlus, National Library of Medicine, as the source. It says A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted; this atlas cites none of them. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote. The raw page is committed in the atlas repository.
    11. Supports Raynaud Phenomenon (MedlinePlus health topic)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Health topic page fetched 2026-11-18. The page shows a last-updated or reviewed date; it is not used here.

      Locator
      What are the types of Raynaud phenomenon?, list item 2, sentence 1
      How it applies
      Secondary Raynaud phenomenon is usually caused by another disease or problem such as lupus or scleroderma.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      e289dc04cd9087c8072918e6d556369e72fbe0ea6a3ea05a2e27edb86836df80
      Reuse basis
      MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source. Terms checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, works produced by the federal government are not copyrighted, and users should acknowledge MedlinePlus, National Library of Medicine, as the source. It says A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted; this atlas cites none of them. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote. The raw page is committed in the atlas repository.
    12. Supports Raynaud Phenomenon (MedlinePlus health topic)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Health topic page fetched 2026-11-18. The page shows a last-updated or reviewed date; it is not used here.

      Locator
      What are the types of Raynaud phenomenon?, list item 2, sentence 3
      How it applies
      The secondary type can be more serious than the primary type.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      e289dc04cd9087c8072918e6d556369e72fbe0ea6a3ea05a2e27edb86836df80
      Reuse basis
      MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source. Terms checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, works produced by the federal government are not copyrighted, and users should acknowledge MedlinePlus, National Library of Medicine, as the source. It says A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted; this atlas cites none of them. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote. The raw page is committed in the atlas repository.
    13. Supports Raynaud Phenomenon (MedlinePlus health topic)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Health topic page fetched 2026-11-18. The page shows a last-updated or reviewed date; it is not used here.

      Locator
      What are the symptoms of Raynaud phenomenon?, paragraph 2, sentence 4
      How it applies
      An attack may last a few minutes or a few hours.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      e289dc04cd9087c8072918e6d556369e72fbe0ea6a3ea05a2e27edb86836df80
      Reuse basis
      MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source. Terms checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, works produced by the federal government are not copyrighted, and users should acknowledge MedlinePlus, National Library of Medicine, as the source. It says A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted; this atlas cites none of them. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote. The raw page is committed in the atlas repository.

Record details

Record id
cardio:raynaud-phenomenon
Content hash
dc27074d7f0dee38707b9524c3f21717315f9190d598b1a0ce3cd7d0624e7f7e